A Critical Appraisal of the Diagnostic and Prognostic Utility of the Anti-Inflammatory Marker IL-37 in a Clinical Setting: A Case Study of Patients with Diabetes Type 2

Background: The role of the cytokine interleukin-37 (IL-37) has been recognized in reversing inflammation-mediated metabolic costs. The aim was to evaluate the clinical utility of this cytokine as a diagnostic and prognostic marker in patients with type 2 diabetes (T2D). Methods: We included 170 old...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosnić, Zvonimir, Babič, František, Anderková, Viera, Štefanić, Mario, Wittlinger, Thomas, Majnarić, Ljiljana Trtica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966907/
https://www.ncbi.nlm.nih.gov/pubmed/36834391
http://dx.doi.org/10.3390/ijerph20043695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966907/
https://www.ncbi.nlm.nih.gov/pubmed/36834391
http://dx.doi.org/10.3390/ijerph20043695

Ejemplares similares